Literature DB >> 19769241

Comparative study of post term and term pregnancy in Nepal Medical College Teaching Hospital (NMCTH).

R Marahatta1, H Tuladhar, S Sharma.   

Abstract

Post term pregnancy (PTP) is one of the commonest obstetric conditions. Pregnancy is called term when it lies between 37 completed weeks to 42 completed weeks (259 to 294 days) from the last menstrual period. If the pregnancy exceeds this period (above 42 completed weeks) it is classified as post term pregnancy. The over all incidence of PTP is 10.0% of all pregnancies. The incidence of PTP varies depending on whether the calculation is based on the history and clinical examination alone, or whether early pregnancy ultrasound examination is used to estimate gestational age. Because of increased risk of maternal and perinatal morbidity and mortality, it is taken as high risk pregnancy. The published data on risk of unexplained intrauterine death associated with PTP vary. It is mostly due to decrease in amniotic fluid volume; meconium passed in utero, placental changes like calcification, abruption placentae and big baby. In present study the prevalence of PTP is 4.6% which is much less than those in different studies. Maternal and neonatal outcomes of pregnancy and related complications were compared with normal term pregnancy. This comparative study revealed increased risk to mother and fetus as pregnancy advances beyond term.

Entities:  

Mesh:

Year:  2009        PMID: 19769241

Source DB:  PubMed          Journal:  Nepal Med Coll J        ISSN: 2676-1319


  2 in total

1.  APPEARANCE OF NEURODEVELOPMENTAL DISORDERS IN CHILDREN DELIVERED POST-TERM: A CROSS-SECTION STUDY.

Authors:  Mladenka Vukojevic; Ines Trninic; Arta Dodaj; Masa Malenica; Tatjana Barisic; Sandra Stojic
Journal:  Mater Sociomed       Date:  2016-03-25

2.  Postpartum Hemorrhage in Pregnancy beyond 40 Weeks of Gestation in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

Authors:  Rashmi Bastakoti Gaire; Suman Raj Tamrakar; Anjana Singh Dongol
Journal:  JNMA J Nepal Med Assoc       Date:  2021-05-25       Impact factor: 0.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.